CAJ | 학술논문

原发性肝癌常伴有脾功能亢进，传统的治疗脾亢的方式是脾切除。随着介入放射学的发展，脾部分栓塞术（ Partial splenic embolization ，PSE）在临床上应用的越来越广泛。肝癌伴脾功能亢进患者通过PSE可明显改善外周血象，降低门脉高压并发症。 PSE联合其他治疗可延长肝癌患者的生存期。现就PSE在肝癌治疗中的临床应用研究做一综述。
원발성간암상반유비공능항진，전통적치료비항적방식시비절제。수착개입방사학적발전，비부분전새술（ Partial splenic embolization ，PSE）재림상상응용적월래월엄범。간암반비공능항진환자통과PSE가명현개선외주혈상，강저문맥고압병발증。 PSE연합기타치료가연장간암환자적생존기。현취PSE재간암치료중적림상응용연구주일종술。
Patients with primary liver cancer are always associated with hypersplenism .The traditional treatment of hypersplenism is splenectomy .With the development of interventional imaging ,partial splenic emboli-zation has been used extensively in clinical practice .Hepatocellular carcinoma with hypersplenism patients by par-tial splenic embolization can obviously improve the blood , reduce the complications of portal hypertension .PSE combined with other treatment can prolong the survival of patients with hepatocellular carcinoma .In this paper ,the clinical application of PSE is reviewed .